Key Details
Price
$610.41Last Dividend
$2.10Annual ROE
24.16%Beta
0.19Events Calendar
Next earnings date:
Jan 10, 2025Recent quarterly earnings:
Oct 15, 2024Recent annual earnings:
Jan 12, 2024Next ex-dividend date:
Dec 09, 2024Recent ex-dividend date:
Sept 16, 2024Next split:
N/ARecent split:
May 31, 2005Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
At the end of the last trading day, UnitedHealth Group (UNH) was priced at $606.79, which represents a 0.16% increase compared to the previous day.
UnitedHealth Group is a stock that has been increasing its dividends and is on track to become a Dividend Aristocrat. In the third quarter, the company reported strong results, exceeding expectations. Additionally, its net debt to adjusted EBITDA ratio is slightly over 1, which helps maintain an A+ credit rating from S&P with a stable outlook.
In 2024, UnitedHealth Group has not performed as well as the overall market, but it may see positive growth in 2025, even with some regulatory challenges. The company reported impressive Q3 results, with earnings per share of $7.15, surpassing expectations, and revenue of $101 billion due to increased service usage. While there are risks like policy uncertainty and possible limits on premium increases, the stock is still considered slightly undervalued, with a target price around $618.
UnitedHealthcare is managing regulatory issues, increasing medical expenses, and a cyberattack while continuing to grow and prepare for long-term success in a strong healthcare market. Even with some short-term difficulties, UNH aims for a long-term earnings growth of 13%-16%, driven by higher health spending and new technologies. Although the Optum Insight and Optum Health divisions are currently facing challenges, they are expected to grow in the future, which will strengthen UNH's focus on value-based care.
Users of Zacks.com have been paying a lot of attention to UnitedHealth (UNH) lately. Therefore, it's important to understand the key factors that could influence the stock's future.
CVS Health, UnitedHealth Group, and Cigna have filed a lawsuit against the Federal Trade Commission, arguing that the agency's case regarding high insulin prices in the U.S. is unconstitutional. This complaint adds to the ongoing legal battle between the three biggest pharmacy benefit managers (PBMs) in the country and the FTC.
In the most recent trading session, UnitedHealth Group (UNH) finished at $589.65, which is a decrease of 0.44% compared to the day before.
This Analyst Blog features UnitedHealth, Bank of America, and SAP SE.
UnitedHealth (UNH) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
The DOJ believes that UNH's purchases show a plan to acquire its rivals instead of competing with them directly, which could allow it to dominate several markets.
FAQ
- What is the primary business of UnitedHealth Group Incorporated?
- What is the ticker symbol for UnitedHealth Group Incorporated?
- Does UnitedHealth Group Incorporated pay dividends?
- What sector is UnitedHealth Group Incorporated in?
- What industry is UnitedHealth Group Incorporated in?
- What country is UnitedHealth Group Incorporated based in?
- When did UnitedHealth Group Incorporated go public?
- Is UnitedHealth Group Incorporated in the S&P 500?
- Is UnitedHealth Group Incorporated in the NASDAQ 100?
- Is UnitedHealth Group Incorporated in the Dow Jones?
- When was UnitedHealth Group Incorporated's last earnings report?
- When does UnitedHealth Group Incorporated report earnings?
- Should I buy UnitedHealth Group Incorporated stock now?